Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors
Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors
Active, not recruiting · NCT06462222 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors | Neoplasms by Site, central nervous system cancer, neoplasm, neoplastic meningitis, nervous system disorder, tumor of meninges | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT06462222 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Medical University | 33 |
| Jinshan Hospital Fudan University | 6 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chest Hospital, Capital Medical University | Beijing | China | 3 |
| Cancer Center, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine | Beijing | China | 1 |
| Huizhou First Hospital Affiliated to Guangdong Medical University | Huizhou | China | 2 |
| Jinshan Hospital, Fudan University | Shanghai | China | 3 |
| The Affiliated Huizhou Hospital, Guangzhou Medical University | Huizhou | China | 6 |